Literature DB >> 17927986

RAC3 down-regulation sensitizes human chronic myeloid leukemia cells to TRAIL-induced apoptosis.

Georgina P Colo1, Roberto R Rosato, Steven Grant, Mónica A Costas.   

Abstract

The nuclear receptor coactivator RAC3 plays important roles in many biological processes and tumorigenesis. We found that RAC3 is over-expressed in human chronic myeloid leukemia cells K562, which are normally resistant to TRAIL-induced apoptosis. RAC3 down-regulation by siRNA rendered these cells sensitive to TRAIL-induced cell death. In addition to the up-regulation of TRAIL receptors, the process involves Bid, caspases and PARP activation, loss of mitochondrial membrane potential, and release of AIF, cytochrome c and Smac/DIABLO to the cytoplasm. We conclude that RAC3 is required for TRAIL resistance and that this anti-apoptotic function is independent of its role in hormone receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17927986     DOI: 10.1016/j.febslet.2007.09.052

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms.

Authors:  M Monika Belickova; Michaela Dostalova Merkerova; Hana Votavova; Jan Valka; Jitka Vesela; Barbora Pejsova; Hana Hajkova; Jiri Klema; Jaroslav Cermak; Anna Jonasova
Journal:  Int J Hematol       Date:  2016-07-14       Impact factor: 2.490

Review 2.  New targets for the antitumor activity of gambogic acid in hematologic malignancies.

Authors:  Li-jing Yang; Yan Chen
Journal:  Acta Pharmacol Sin       Date:  2012-12-31       Impact factor: 6.150

3.  Overexpression of AIB1 correlates inversely with E-cadherin expression in pancreatic adenocarcinoma and may promote lymph node metastasis.

Authors:  Si Guo; JingJing Xu; Rui Xue; YuQiong Liu; HaiBo Yu
Journal:  Int J Clin Oncol       Date:  2013-03-30       Impact factor: 3.402

4.  The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo.

Authors:  Girija Dasmahapatra; Dmitry Lembersky; Lora Kramer; Richard I Fisher; Jonathan Friedberg; Paul Dent; Steven Grant
Journal:  Blood       Date:  2010-03-16       Impact factor: 22.113

5.  The role of AIB1 in breast cancer.

Authors:  Alan K Chang; Huijian Wu
Journal:  Oncol Lett       Date:  2012-07-16       Impact factor: 2.967

6.  Involvement of SRC-3 in deguelin-induced apoptosis in Jurkat cells.

Authors:  Rui Li; Yan Chen; Wen-xiu Shu; Zi Chen; Wen-juan Ke
Journal:  Int J Hematol       Date:  2009-04-14       Impact factor: 2.490

Review 7.  SRC-3 has a role in cancer other than as a nuclear receptor coactivator.

Authors:  Gang Ma; Yu Ren; Ke Wang; Jianjun He
Journal:  Int J Biol Sci       Date:  2011-05-24       Impact factor: 6.580

8.  RAC3 more than a nuclear receptor coactivator: a key inhibitor of senescence that is downregulated in aging.

Authors:  P N Fernández Larrosa; M Ruíz Grecco; D Mengual Gómez; C V Alvarado; L C Panelo; M F Rubio; D F Alonso; D E Gómez; M A Costas
Journal:  Cell Death Dis       Date:  2015-10-15       Impact factor: 8.469

9.  Impaired hematopoiesis and delayed thrombopoietic recovery following sublethal irradiation in SRC‑3 knockout mice.

Authors:  J Jin; Y Wang; J Wang; Y Xu; S L Chen; J P Wang; Y P Su
Journal:  Mol Med Rep       Date:  2014-03-12       Impact factor: 2.952

10.  Increased radiosensitivity and radiation-induced apoptosis in SRC-3 knockout mice.

Authors:  Jie Jin; Yu Wang; Jin Wang; Yang Xu; Shilei Chen; Junping Wang; Xinze Ran; Yongping Su
Journal:  J Radiat Res       Date:  2013-12-05       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.